Technical analysis of Zai Lab Limited (ZLAB): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Operating primarily in Mainland China and Hong Kong, Zai Lab Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medical treatments. Their therapeutic portfolio spans oncology, autoimmune conditions, infectious diseases, and neurological disorders.
Price Performance
| 1 month | -3.17% |
| 3 months | +36.20% |
| Year-to-date | +40.36% |
| 1 year | -24.00% |
| 3 years | -3.96% |
| 5 years | -80.75% |
52-Week Range
| 52-week High | $34.72 |
| 52-week Low | $15.96 |
| Avg Volume (90d) | 970K |
Technical Indicators
| SMA 50 | $22.87 |
| SMA 200 | $19.99 |
| Beta | 0.86 |
| 30-day Volatility (annualised) | 63.7% |
| Price vs SMA 50 | +8.3% |
| Price vs SMA 200 | +23.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $26.13 | |
| 2025-11 | $20.41 | -21.9% |
| 2025-12 | $17.64 | -13.6% |
| 2026-01 | $16.60 | -5.9% |
| 2026-02 | $19.22 | +15.8% |
| 2026-03 | $18.81 | -2.1% |
| 2026-04 | $21.64 | +15.0% |
| 2026-05 | $17.69 | -18.3% |
| 2026-06 | $19.00 | +7.4% |
| 2026-07 | $18.27 | -3.8% |
| 2026-08 | $25.46 | +39.4% |
| 2026-09 | $24.76 | -2.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | $0.10 | $672M |
| 2026-09-14 | $-0.00 | $3M |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
Price
| Price | $24.67 |
| Market Cap | $2.8B |
| Exchange | NASDAQ |
| Country | CN |
Valuation Ratios
| Price / Book | 2.76 |
| EV / EBITDA | -9.33 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.31 |
| Current Ratio | 2.45 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -0.22 |